scorecard
  1. Home
  2. Science
  3. CVS just decided against selling uBiome's poop-testing kits, dealing another blow to the bankrupt startup

CVS just decided against selling uBiome's poop-testing kits, dealing another blow to the bankrupt startup

CVS just decided against selling uBiome's poop-testing kits, dealing another blow to the bankrupt startup

ubiome 3

Erin Brodwin

A uBiome Explorer test kit.

  • CVS has decided not to stock uBiome's sole remaining product, an at-home microbiome test called $4.
  • $4 was counting on selling the kits in CVS stores as part of a plan to $4 and show it still has value.
  • "Given the circumstances surrounding uBiome, we'll be stopping shipments and, in the event product has already arrived in store, marking it as 'do not sell,'" a CVS spokesperson said.
  • $4 yesterday, as it faces refund demands from health insurers and potential fines from ongoing civil and criminal investigations.
  • $4.

Poop-testing startup $4 is facing yet another setback, a day after $4.

The massive pharmacy chain $4 has decided it won't stock uBiome's testing kits in its stores, according to a CVS spokesman. uBiome was counting on selling the kits in CVS stores as part of a plan to $4 and to demonstrate to potential acquirers that the company still has value.

"Simply put, uBiome needs a clean slate and a fresh start to save the business and 100 jobs," uBiome acting CEO Curtis Solsvig said in a $4.

uBiome didn't immediately respond to a request for comment.

The company said in its bankruptcy filing that it hopes to entice an investor to purchase it for its scientific knowledge of the microbiome, the trillions of bacteria that live in and on our bodies. uBiome said it had approached 180 potential acquirers, but couldn't seal a deal. Potential uBiome buyers face risks that include civil and criminal penalties resulting from ongoing investigations into uBiome's business practices, the document said.

"Given the circumstances surrounding uBiome, we'll be stopping shipments and, in the event product has already arrived in store, marking it as 'do not sell,'" TJ Crawford, a CVS spokesman, told Business Insider by email.

Read more: $4

The company has been in $4 for several months, after the startup's problems burst into public view following an $4 in April. uBiome is currently under $4 related to its billing practices, and $4 earlier this summer.

In addition, insiders told Business Insider that key science was $4 from the start, prompting the company to start an $4 A top science journal where uBiome published its basic research is $4.

The kits that uBiome planned to sell at CVS stores are known as the $4. uBiome also sells them on its website for $89. To take an $4 you sample your poop at home, and send it to uBiome for analysis.

Then you get back an online report comparing the bacteria in your gut to that of other uBiome volunteers in the company's database. The company says that the results aren't supposed to be used to diagnose or treat diseases.

>$4

NOW WATCH: $4

READ MORE ARTICLES ON



Popular Right Now



Advertisement